CINECA IRIS Institutional Research Information System

VITTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.270
EU - Europa 20.396
AS - Asia 14.644
SA - Sud America 2.177
AF - Africa 714
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 15
Totale 75.267
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.978
IT - Italia 10.141
CN - Cina 4.536
SG - Singapore 4.325
CA - Canada 3.099
HK - Hong Kong 2.681
SE - Svezia 2.488
DE - Germania 2.263
BR - Brasile 1.831
BG - Bulgaria 1.177
GB - Regno Unito 890
TR - Turchia 813
VN - Vietnam 793
RU - Federazione Russa 539
FI - Finlandia 482
UA - Ucraina 463
AT - Austria 419
FR - Francia 392
NL - Olanda 391
IN - India 323
KR - Corea 310
CI - Costa d'Avorio 287
CH - Svizzera 164
JP - Giappone 164
SN - Senegal 146
AR - Argentina 113
BD - Bangladesh 112
BE - Belgio 95
MX - Messico 95
PL - Polonia 94
ZA - Sudafrica 74
PK - Pakistan 72
IQ - Iraq 71
ES - Italia 70
IE - Irlanda 66
ID - Indonesia 61
EC - Ecuador 57
SA - Arabia Saudita 48
GR - Grecia 47
UZ - Uzbekistan 45
AU - Australia 42
NG - Nigeria 41
PY - Paraguay 38
MY - Malesia 35
RO - Romania 34
VE - Venezuela 34
CO - Colombia 31
IR - Iran 30
EG - Egitto 28
MA - Marocco 27
CL - Cile 24
IL - Israele 24
CZ - Repubblica Ceca 23
KE - Kenya 23
LT - Lituania 23
LV - Lettonia 23
UY - Uruguay 23
JO - Giordania 21
DZ - Algeria 18
PE - Perù 17
CR - Costa Rica 16
PH - Filippine 16
AE - Emirati Arabi Uniti 15
BJ - Benin 15
NP - Nepal 15
AZ - Azerbaigian 14
EE - Estonia 14
KZ - Kazakistan 14
PA - Panama 14
TT - Trinidad e Tobago 14
HU - Ungheria 13
TW - Taiwan 13
ZM - Zambia 13
AL - Albania 12
OM - Oman 12
DK - Danimarca 11
EU - Europa 11
TN - Tunisia 11
JM - Giamaica 10
PS - Palestinian Territory 10
TH - Thailandia 10
NO - Norvegia 9
NZ - Nuova Zelanda 9
RS - Serbia 9
GT - Guatemala 8
HR - Croazia 8
KG - Kirghizistan 8
BH - Bahrain 7
GE - Georgia 7
SM - San Marino 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
LY - Libia 6
PT - Portogallo 6
BB - Barbados 5
CY - Cipro 5
GA - Gabon 5
HN - Honduras 5
LB - Libano 5
Totale 75.174
Salva come PNG Salva come JPEG
Città #
Ashburn 3.810
Woodbridge 3.414
Fairfield 3.272
Hong Kong 2.637
Ann Arbor 2.473
Houston 2.433
Montreal 2.353
Singapore 2.352
Chandler 2.156
Dallas 1.642
Santa Clara 1.628
Milan 1.490
Seattle 1.365
Wilmington 1.202
Sofia 1.173
Cambridge 1.058
Beijing 999
Shanghai 998
New York 802
Ottawa 632
Rome 551
Boardman 510
Princeton 510
Serra 476
Jacksonville 451
Lawrence 449
Izmir 448
Los Angeles 437
Hefei 409
Medford 400
Vienna 368
Florence 347
Nanjing 340
Des Moines 327
Seoul 291
Abidjan 286
Munich 262
Istanbul 235
Dearborn 203
Frankfurt am Main 191
Pisa 183
Buffalo 170
Dong Ket 169
Redondo Beach 162
Naples 161
London 160
Boulder 159
São Paulo 159
San Diego 153
Ho Chi Minh City 148
Dakar 146
The Dalles 139
Columbus 135
Redwood City 122
Tokyo 121
Bologna 120
Falls Church 119
Nanchang 118
Bern 116
Bremen 115
Jüchen 100
Palermo 99
Menlo Park 98
Bari 96
Ogden 93
Lancaster 92
Brussels 85
Hanoi 85
Turin 84
Council Bluffs 82
Kunming 82
Shenyang 81
Hebei 74
Düsseldorf 73
Catania 72
Fuzhou 71
Guangzhou 70
Marseille 70
Changsha 66
Tianjin 66
Turku 65
Brescia 61
Washington 60
Chicago 58
Helsinki 58
Detroit 57
Jiaxing 56
Rio de Janeiro 55
Phoenix 52
Jinan 50
Padova 49
San Jose 49
Belo Horizonte 47
Brooklyn 46
Paris 46
Genoa 45
Toronto 43
Warsaw 43
Kocaeli 42
Quanzhou 42
Totale 50.918
Salva come PNG Salva come JPEG
Nome #
Tiroidite cronica autoimmune 10.052
Ontogenetic development of pancreatic thyrotropin-releasing hormone in human foetuses and in infants. 345
The role of nuclear medicine in the clinical management of benign thyroid disorders. Part 1. Hyperthyroidism 320
Natural history of graves’ orbitopathy after treatment 253
Identification of a novel mutation in the polymerase delta 1 (POLD1) gene in a lipodystrophic patient affected by mandibular hypoplasia, deafness, progeroid features (MDPL) syndrome 251
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 241
Artificial neural networks in the outcome prediction of adjustable gastric banding in obese women. 238
Gozzo diffuso tossico (morbo di Flajani-Basedow-Graves) e tiroidite cronica autoimmune, Inquadramento nosologico e terapia medica 235
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 235
Leonardo da Vinci "Design of Lady with Graves' disease" (1452-1519) 229
Sera of patients with idiopathic myxedema contain IgG which block TSH-stimulated thyroid adenylate cyclase 226
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. 226
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 225
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 224
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 224
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 221
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 221
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 219
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 216
Proteomic analysis of fine-needle aspiration in differential diagnosis of thyroid nodules. 216
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer 214
Expression of the microsomal antigen on the surface of continuously cultured rat thyroid cells is modulated by thyrotropin. 213
Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding 213
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? 210
V804M RET MUTATION AND VANDETANIB RESPONSE IN METASTATIC MEDULLARY THYROID CANCER 206
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 206
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer 205
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 204
uptake of amiodarone by thyroidal and non-thyroidal cell lines 201
Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. 200
Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. 200
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib 200
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 199
Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. 198
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 198
A study on the relationship between intraglandular arterial distribution and thyroid lobe shape: implications for biotechnology of a bioartificial thyroid 197
In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity 197
Molecular interactions at the cell surface: role of glycoconjugates and membrane lipids in receptor recognition processes. 196
Effects Of Long-term Tamoxifen Therapy On The Course Of Chronic Autoimmune Thyroiditis 196
Thyrotropin stimulation of the ADP-ribosyltransferase activity of bovine thyroid membranes. 195
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 195
Thyroid-stimulating antibody mimics thyrotropin in its ability to desensitize the adenosine 3',5'-monophosphate response to acute stimulation in continuously cultured rat thyroid cells (FRT-L5). 193
Effects of bariatric surgery on preclinical myocardial alterations in severe obesity 191
Results of Vardenafil Mediated Power Doppler Ultrasound, Contrast Enhanced Ultrasound and Systematic Random Biopsies to Detect Prostate Cancer 191
Causes and laboratory investigations of thyrotoxicosis 191
STUDY OF POTENTIAL INHIBITORS OF THYROID IODIDE UPTAKE BY USING CHO CELLS STABLY EXPRESSING THE HUMAN SODIUM/IODIDE SYMPORTER (hNIS) PROTEIN 189
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 189
Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. 188
Diagnosis of thyroid dysfunction: present and future. 188
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 188
Interference of serum thyroglobulin in the radioassay for serum antithyroglobulin antibodies. 187
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue 187
Thyroglobulin Antibodies (TgAb) Titer Spontaneously Decrease Until The Negativization Or Stabilization In Most Of Cases Of Papillary Thyroid Microcarcinoma (mPTC) Treated With Total Thyroidectomy But Not Ablated With 131I 186
Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology 185
Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules 184
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 184
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre 184
Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. 183
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 183
Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts 183
Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women 182
DIAGNOSTIC AND THERAPEUTIC ROLE OF THYROID REMNANT ABLATION WITH LOW ACTIVITY OF 131I IN PATIENTS WITH LOW AND INTERMEDIATE RISK PAPILLARY THYROID CARCINOMA (PTC). 182
Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay. 180
Effect of thyroglobulin autoantibodies on the metabolic clearance of serum thyroglobulin 180
Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease 179
Electric and magnetic fields do not modify the biochemical properties of FRTL-5 cells 179
Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center 179
Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma 178
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 178
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 178
Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease. 177
Agretti P, De Marco G, De Servi M, Marcocci C, Vitti P, Pinchera A, Tonacchera M.: Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation 177
Prevalence of thyroid peroxidase, thyroglobulin and thyrotropin receptor antibodies in a long-term follow-up of juvenile Graves disease 177
Thyroglobulin Autoantibodies arise before Thyroperoxidase Autoantibodies in Juvenile Autoimmune Thyroiditis 177
Thyroid autoimmunity, thyroglobulin autoantibodies and thyroid cancer prognosis 176
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 176
[Thyroid-stimulating immunoglobulins. The related antigens] 174
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 174
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 174
Radioactive iodine (131I) effects on male fertility 173
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 173
Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease. 173
ROLE OF THYROID REMNANT ABLATION WITH LOW ACTIVITY OF 131I IN PATIENTS WITH LOW AND INTERMEDIATE RISK PAPILLARY THYROID CARCINOMA (PTC). 173
Graves' Disease Induced by Immune Checkpoint Inhibitors: A case report and Review of the literature 173
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters 172
The expression of platelet serotonin transporter (SERT) in human obesity 172
Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato 172
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 172
Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter. 171
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO) 171
Lipodystrophy and obesity are associated with decreased number of T cells with regulatory function and pro-inflammatory macrophage phenotype 171
Percutaneous ethanol injection: what is its role in the management of nodular lesions of endocrine glands? 170
Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma 170
Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter 169
Gonadotrophin receptor blocking antibodies measured by the use of cell lines stably expressing human gonadotrophin receptors are not detectable in women with 46,XX premature ovarian failure 169
mRECIST criteria to assess recurrent thyroid carcinoma treatment response after radiofrequency ablation: a prospective study 169
TSH receptor antibodies do not alter the function of gonadotropin receptors stably expressed in eukaryotic cells 169
Iodine deficiency from pregnancy to childhood 169
Thyroid volume in children: role of iodine intake. 168
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. 168
Totale 29.378
Salva come PNG Salva come JPEG
Categoria #
all - tutte 191.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 191.493
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.647 0 0 0 0 0 289 249 407 355 493 269 585
2021/20225.838 112 234 135 381 1.193 832 173 268 465 364 239 1.442
2022/20237.883 850 944 578 646 816 912 173 607 1.317 168 638 234
2023/20249.119 736 622 685 438 805 1.005 376 540 246 2.616 395 655
2024/202516.137 293 716 409 1.108 1.498 1.469 1.247 981 1.686 2.141 1.622 2.967
2025/20269.548 1.234 2.043 1.894 1.521 1.664 1.192 0 0 0 0 0 0
Totale 76.094